Funding a Study for LDN and MS

[Guest guest]

In my opinion, the two most logical places to campaign for funding for

studies to gain approval for LDN in the treatment of MS are with the

non-profit MS organizations who should have ALREADY funded the studies

on their own, and with the health insurance companies, most notably

Blue Cross. With profits as a detracting feature for pharmaceutical

companies, it would seem that MILLIONS could be saved by insurance

companies if LDN proved to be a worthy substitute for the ABCRs. It

certainly has replaced them for me, and the total cost of LDN is lower

than the co-pay for the ABCRs.

The problem here, however, lies in being able to actually talk to a

human being at the insurance company. I think it's easier to find a

four-leaf clover in a lawn of zoysia than talking to a person at Blue

Cross. Thanks, BMR